Lawrence Klein
Net worth: 54 M $ as of 31/05/2026
Net worth: 54 M $ as of 31/05/2026
Lawrence O. Klein is on the board of Dyne Therapeutics, Inc. and Chief Operating & Business Officer at CRISPR Therapeutics AG. Dr. Klein previously occupied the position of Associate Partner at Mckinsey & Co. (Switzerland). Dr. Klein received a doctorate from Stanford University and an undergraduate degree from the University of Wisconsin.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
1.91% | 15/06/2026 | 9,25,580 ( 1.91% ) | 54 M $ | 31/05/2026 |
| 09/06/2026 | 70 ( 0% ) | 1 473 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| JADE BIOSCIENCES, INC. | Director/Board Member | 28/04/2025 |
| Companies | Position | End |
|---|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Private Equity Investor | 01/02/2024 |
| JASPER THERAPEUTICS, INC. | Director/Board Member | 20/06/2023 |
| DYNE THERAPEUTICS, INC. | Director/Board Member | 24/05/2023 |
| CRISPR THERAPEUTICS AG | Chief Operating Officer | 01/10/2022 |
Mckinsey & Co. (Switzerland)
Mckinsey & Co. (Switzerland) Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Corporate Officer/Principal | 01/02/2016 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Mckinsey & Co. (Switzerland)
Mckinsey & Co. (Switzerland) Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Commercial Services |
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Select your edition
All financial news and data tailored to specific country editions